Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

BACKGROUND: Pancreatic Ductal Adenocarcinoma (PDAC) is a highly aggressive malignancy with only a 5% 5-year survival rate. Reliable biomarkers for early detection are still lacking. The goals of this study were (a) to identify early humoral responses in genetically engineered mice (GEM) spontaneousl...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Capello, Michela, Cappello, Paola, Linty, Federica Caterina, Chiarle, Roberto, Sperduti, Isabella, Novarino, Anna, Salacone, Paola, Mandili, Giorgia, Naccarati, Alessio, Sacerdote, Carlotta, Beghelli, Stefania, Bersani, Samantha, Barbi, Stefano, Bassi, Claudio, Scarpa, Aldo, Nisticò, Paola, Giovarelli, Mirella, Vineis, Paolo, Milella, Michele, Novelli, Francesco
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2013
विषय:
Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3844582/
https://ncbi.nlm.nih.gov/pubmed/24010981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-67
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन